Literature DB >> 1832218

Proteolysis of splicing factors during rat and monkey cell fractionation.

H La Branche1, D Frappier, B Chabot.   

Abstract

We have investigated the ability of various rat and monkey cell lines to yield nuclear extracts that would allow splicing of a model adenovirus pre-mRNA substrate. Extracts from normal FR3T3, rat-1 and CV-1 fibroblasts were unable to assemble splicing complexes and displayed a dramatic reduction in the binding activity of the splicing factor 65 kD U2AF. These results correlated with reduced levels of 65 kD U2AF and the snRNP-associated B protein. When a battery of protease inhibitors was used during cell fractionation, increased levels of 65 kD U2AF and B proteins were detected. Most importantly, U2AF binding and complex formation were dramatically improved in FR3T3, rat-1 and CV-1 extracts. Interestingly, transformation of rat and monkey cells with the SV40 large T antigen yielded extracts active in complex formation. Similar extracts were generated following transformation of rat-1 cells with the Py middle T antigen but not with the v-fos oncogene. Only SV40-transformed FR3T3 extracts displayed splicing activity. Our results indicate that proteolysis is a major obstacle encountered during the preparation of active extracts from normal rat and monkey cells and suggest that cells transformed with T antigens manifest reduced proteolysis during fractionation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832218      PMCID: PMC328642          DOI: 10.1093/nar/19.16.4509

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing.

Authors:  K A Lee; A Bindereif; M R Green
Journal:  Gene Anal Tech       Date:  1988 Mar-Apr

2.  Presplicing complex formation requires two proteins and U2 snRNP.

Authors:  A Krämer
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

3.  Accurate and efficient in vitro splicing of purified precursor RNAs specified by early region 2 of the adenovirus 2 genome.

Authors:  C J Goldenberg; S D Hauser
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

4.  mlt Mutation in the polyomavirus genome impairing a function of the middle T protein.

Authors:  C Gelinas; S Masse; M Bastin
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

5.  An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences.

Authors:  F Weber; J de Villiers; W Schaffner
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

6.  Alternative splicing caused by RNA secondary structure.

Authors:  D Solnick
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

7.  Intrachromosomal recombination mediated by papovavirus large T antigens.

Authors:  L St-Onge; L Bouchard; S Laurent; M Bastin
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro.

Authors:  A R Krainer; T Maniatis; B Ruskin; M R Green
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

9.  FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.

Authors:  T Curran; G Peters; C Van Beveren; N M Teich; I M Verma
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

10.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more
  2 in total

1.  An exonic splicing silencer in the testes-specific DNA ligase III beta exon.

Authors:  S L Chew; L Baginsky; I C Eperon
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions.

Authors:  Y Shav-Tal; M Cohen; S Lapter; B Dye; J G Patton; J Vandekerckhove; D Zipori
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.